BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10587982)

  • 1. Long-term follow-up in hematopoietic stem-cell transplant patients.
    Fisher VL
    Pediatr Transplant; 1999; 3 Suppl 1():122-9. PubMed ID: 10587982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
    Gifford G; Sim J; Horne A; Ma D
    Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children.
    Baker KS; Bresters D; Sande JE
    Pediatr Clin North Am; 2010 Feb; 57(1):323-42. PubMed ID: 20307723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell transplantation: supportive care and long-term complications.
    Wingard JR; Vogelsang GB; Deeg HJ
    Hematology Am Soc Hematol Educ Program; 2002; ():422-44. PubMed ID: 12446435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
    Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
    Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Genital Examination and Vulvovaginal Graft-Versus-Host Disease in a Pediatric Post-Hematopoietic Stem Cell Transplant Population.
    Allen SM; Liang CS; Chesnokova AE; Childress KJ; Pascoe KF; Dietrich JE
    J Pediatr Adolesc Gynecol; 2020 Dec; 33(6):658-666. PubMed ID: 32781233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late effects following hematopoietic cell transplantation for children.
    Dahllöf G; Hingorani SR; Sanders JE
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):88-93. PubMed ID: 18162227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy.
    Khalil A; Zaidman I; Elhasid R; Peretz-Nahum M; Futerman B; Ben-Arush M
    Pediatr Hematol Oncol; 2012 Nov; 29(8):694-703. PubMed ID: 23020512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Hematopoietic Stem Cell Transplantation-Associated Bone Loss.
    Khan Z; Agarwal NB; Bhurani D; Khan MA
    Transplant Cell Ther; 2021 Mar; 27(3):212-221. PubMed ID: 33045384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogammaglobulinemia in children after allogeneic hematopoietic stem cell transplantation: a cytokine mediated immunoglobulin isotype class switch arrest?
    Sundin M; Remberger M; Lindqvist H; Omazic B; Sundberg B; Uzunel M; Winiarski J
    Pediatr Blood Cancer; 2015 May; 62(5):890-6. PubMed ID: 25623620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular mechanism for granulocyte-colony stimulating factor in the prevention of graft-versus-host disease in combined bone marrow and peripheral blood transplantation for hematological malignancies: the composition in collection.
    Zhang C; Zhang X; Chen XH
    Transfus Apher Sci; 2013 Feb; 48(1):3-9. PubMed ID: 23279971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.
    Abou-Mourad YR; Lau BC; Barnett MJ; Forrest DL; Hogge DE; Nantel SH; Nevill TJ; Shepherd JD; Smith CA; Song KW; Sutherland HJ; Toze CL; Lavoie JC
    Bone Marrow Transplant; 2010 Feb; 45(2):295-302. PubMed ID: 19597425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive outcomes in pediatric hematological cancer survivors post-HSCT: A systematic review.
    Ansari S; Garg A; Khan MA
    Clin Transplant; 2024 Jan; 38(1):e15193. PubMed ID: 37964657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell transplantation: a review and recommendations for follow-up care for the general practitioner.
    Passweg JR; Halter J; Bucher C; Gerull S; Heim D; Rovó A; Buser A; Stern M; Tichelli A
    Swiss Med Wkly; 2012; 142():w13696. PubMed ID: 23135685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challenges.
    Bhatia S; Davies SM; Scott Baker K; Pulsipher MA; Hansen JA
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1428-35. PubMed ID: 21763253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices.
    Tichelli A; Rovó A; Gratwohl A
    Hematology Am Soc Hematol Educ Program; 2008; ():125-33. PubMed ID: 19074070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-hematopietic stem cell transplant complications].
    de Berranger E; Jubert C; Michel G
    Bull Cancer; 2015; 102(7-8):648-55. PubMed ID: 25962541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up.
    Wilhelmsson M; Vatanen A; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
    Bone Marrow Transplant; 2015 Jun; 50(6):850-7. PubMed ID: 25798676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.